Mammalian and Drosophila homologues of Baf57 have been previously isolated as being a subunit of SWI/SNF-like chromatin remodeling complexes. Here, we report the cloning and developmental expression of Xenopus Baf57. We isolated XBaf57 by using an expression cloning approach to identify novel modulators of Xenopus Smad7. XBaf57 co-operates with XSmad7 by increasing the expression of neural markers in ectodermal explants. XBaf57 is expressed in the ectoderm and pre-involuting mesoderm during gastrula stages and in the central nervous system during neurula and tailbud stages. These results raise the possibility that XBaf57 (or XBaf57-containing chromatin remodelling complexes) may be involved in the process of neural induction during Xenopus embryonic development. q
Results and discussion
The formation of the vertebrate nervous system is initiated at gastrula stages of development, when secreted inhibitors of the bone morphogenetic proteins (BMP) signaling pathway are released from the organizer and induce the overlaying ectoderm (reviewed in Weinstein and Hemmati-Brivanlou, 1999) . BMPs are members of the Transforming growth factor-b (TGF-b) superfamily of secreted proteins, which signal through the activation of heteromeric complexes of transmembrane type I and type II Ser/Thr kinase receptors and the Smad family of intracellular effector proteins (reviewed in Wrana, 2000) . Smads are classified into three groups according to their activity: the receptor regulated Smads (R-Smads); the common Smads (Co-Smads); and the inhibitory Smads (I-Smads). XSmad7 is an inhibitory Smad that represses both the BMP and Activin pathways during Xenopus embryonic development. XSmad7 induces neural tissue in ectodermal explants and inhibits mesoderm formation in the embryo (Casellas and Hemmati-Brivanlou, 1998) .
The mechanism of inhibition of Activin pathway by Smad7 is relatively well understood. Mammalian Smad7 was shown to bind the TGF-b type I receptor and to inhibit the activation of Smad2 (Hayashi et al., 1997; Nakao et al., 1997) and human Smad7 was proposed to mediate the interaction of the TGF-b receptor with Smurf-2, a ubiquitin ligase that targets the receptor complex for degradation via the proteosomal pathway (Kavsak et al., 2000) . On the other hand, less is known about how Smad7 represses the BMP signaling pathway. For this reason, we undertook an expression cloning screen in Xenopus ectodermal explants, designed to identify novel genes able to synergise with XSmad7 in the repression of BMP signaling. From this screen we isolated the Xenopus homologue of Baf57. Mammalian (Wang et al., 1998) and Drosophila (Papoulas et al., 2001 ) homologues of Baf57 have been previously isolated as encoding a subunit of SWI/SNF-like chromatin remodeling complexes. These complexes contain an adenosine triphosphatase (ATP-ase) subunit which is encoded by the genes brahma or brahma related gene 1 (Brg1) and other subunits that were denominated Brg1 associated factors (BAFs) in mammals or BAPs (Brahma Associated Protein) in Drosophila. However, in these reports no information about the expression of Baf57 during the embryonic development or possible functional interactions with known signaling pathways was provided. In this paper, we describe the expression cloning of XBaf57 as a modulator of XSmad7 and the developmental expression of XBaf57.
Molecular cloning of XBaf57
In order to identify modulators of XSmad7, we undertook a modifier screen based on an expression cloning strategy Harland, 1991, 1992; Weinstein et al., 1998) . We injected the animal pole of two cell stage Xenopus embryos with a sub-optimal amount of XSmad7 RNA (5 pg/embryo) together with synthetic RNAs from pools of 100 clones from a gastrula-stage cDNA library (Fig. 1) . Animal pole explants from injected embryos were excised at blastula stage and cultured until early tailbud stage when gene expression was assayed by reverse transcriptase-polymerase chain reaction (RT-PCR). We looked for pools able to co-operate with XSmad7 to increase the induction of neural markers in the explants. Sib-selection of one of these pools led to the isolation of single clone 504-1F. When microinjected alone, 504-1F did not significantly induce the expression of neural markers Nrp1 and Otx (Fig. 2, lane 7) . However, injection of 504-1F RNA together with XSmad7 RNA increased the expression of Nrp1 and Otx (Fig. 2 , lanes 5, 6) when compared with XSmad7 alone (Fig. 2, lane 4) . No neural crest (slug), posterior neural (Hoxb9) or mesodermal (muscle actin) markers were induced.
Sequence analysis revealed that the insert contained a full length 1269 bp open reading frame (ORF) encoding a putative 423 amino acid protein. Sequence comparison with the databases showed that this ORF corresponds to the Xenopus homologue of the human and mouse Baf57 (Wang et al., 1998) protein and Drosophila BAP111 (Papoulas et al., 2001) . The predicted amino acid sequence of XBaf57 shares 86, 85 and 34% identity with mouse, human and Drosophila homologues, respectively (Fig. 3) . Two domains of high conservation are found between amino acid positions 77-147 and 173-274. The first corresponds to an HMG DNA binding domain, while the second presents homology to the coiled-coil region of kinesin (Papoulas et al., 2001; Wang et al., 1998 ).
XBaf57 expression during early embryonic development
RT-PCR analysis reveals that XBaf57 is expressed maternally during early cleavage stages and expression continues during gastrula, neurula, tailbud and tadpole stages (Fig.  4A) . Whole mount in situ hybridization shows high levels of XBaf57 expression in the ectoderm and marginal zone in early gastrula embryos (stage 10.5) (Fig. 4B) . A sagittal section of the embryo shows that XBaf57 expression is restricted to the pre-involuting mesoderm above the dorsal blastopore lip (Fig. 4C) . At stage 12, XBaf57 is expressed in the ectoderm but not the involuted mesoderm or yolk plug (Fig. 4D, E) . At neurula stage (stage 14), expression is stronger in the neural plate and in the border between the Fig. 1 . Expression cloning strategy. A gastrula (stage 10.5) expression cDNA library was divided into pools containing 100 clones each. RNA was synthesized from each pool by in vitro transcription and was microinjected into animal poles of two cell stage embryos. Ectodermal explants were isolated from the injected embryos and were cultured until early tailbud stage, when gene expression was assayed by RT-PCR. A pool that was able to increase the induction of neural markers when co-injected with XSmad7 was sub-divided into smaller pools that were retested until an active single clone was isolated. Fig. 2 . Clone 504-1F (XBaf57) co-operates with XSmad7 to induce neural markers in animal caps. RT-PCR of animal caps injected with the indicated amounts of XSmad7 and XBaf57 RNA. The expression of the neural markers Nrp1 and Otx increased when XBaf57 was co-injected with XSmad7. XBaf57 alone did not significantly induce neural markers. The neural crest marker slug, the posterior neural marker Hoxb9 and the mesodermal marker muscle actin were not induced by XBaf57 alone or in combination with XSmad7. All samples were analyzed at stage 20. RT 2 is a negative control where no reverse transcriptase was added to embryo RNA during cDNA synthesis. EF1a was used as loading control. neural plate and epidermal ectoderm (Fig. 4F) . In tailbudstage embryos, XBaf57 is expressed throughout the central nervous system, in the forebrain, midbrain and hindbrain and with weaker expression in the posterior spinal cord (Fig. 4G) . In the tadpole, other domains of expression include the eye, branchial arches, otic vesicle and tail bud (Fig. 4H) . Observation of a cleared specimen reveals weaker expression of XBaf57 in vascular structures such as the posterior cardinal vein, intersomitic vessels and the vascular vitelline network (Fig. 4I) . Hybridization with the negative control sense probe did not produce any staining (data not shown).
The comparison between the expression of XBaf57 described above and XSmad7 pattern of expression (Casellas and Hemmati-Brivanlou, 1998) reveals domains of overlap. During gastrulation both genes are expressed in the ectodermal layer that will later form neural tissue. At tailbud and tadpole stages sites of overlap include the eyes, otic vesicle and hindbrain. This overlap in expression patterns is consistent with the possible interaction of these two proteins during embryonic development.
Materials and methods

Xenopus embryos and expression screening
Xenopus embryos were obtained by in vitro fertilization, dejellied with 3.5% cysteine and staged according to Nieuwkoop and Faber (1967) . Microinjections were performed as described (Brivanlou and Harland, 1989) . For the expression screen, 5 ng of RNA from each pool of Fig. 3 . Comparison of the predicted amino acid sequence of Xenopus Baf57 (XBaf57) with mouse (mBaf57), human (hBaf57) and Drosophila (dBap111) homologues. XBaf57 GenBank accession number: AF487782 100 clones of the gastrula cDNA library was co-injected with 5 pg of XSmad7 RNA into the animal pole of two cell stage embryos. Animal pole explants were excised at stage 8-9 and cultured in 0.5 £ MMR until early tailbud stage, when gene expression was assayed by RT-PCR. The sib-selection of a positive pool was performed by sub-division of the corresponding bacterial stock into 20 pools with 10 clones/each that were retested, and finally the assay of each individual clone from the pool of 10 clones.
RT-PCR assay
The RT-PCR analysis of gene expression was performed as previously described (Chang et al., 1997) . The primers used were: XBaf57 (U: 5 0 -GCTTCTATGGAAGAGGTCTG and D: ACTTGGTCCCAGACCTTCCT), EF1a (Krieg et al., 1989) , Histone H4 and Otx (Suzuki and Brivanlou, 2000) , NRP1 (Suzuki et al., 1997) , slug, Hoxb9 and muscle actin (Chang and Hemmati-Brivanlou, 1998 ).
Whole-mount in situ hybridization
Xenopus embryos were fixed in MEMFA and processed for whole mount in situ hybridization as described previously (Harland, 1991) . Embryos were cleared by treatment with benzyl alcohol/benzyl benzoate (1:2). 
